Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: Impact on the autonomic control of blood pressure

British Journal of Pharmacology

Volumn 148, Issue 1, 2006, Pages 25-38

  Cloutier, Frank ^a,c   Ongali, Brice ^a   Deschamps, Kathleen ^a   Brouillette, Jonathan ^a   Neugebauer, Witold ^b   Couture, Réjean ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Sar 9,Met(O 2) 11 SP, NK 1 and NK 3 receptors; Autoradiography; Blood pressure; Hypertension; Senktide; Spinal cord; Tachykinins

Indexed keywords

[3 (4 HYDROXYPHENYL)PROPYL]ASPARTYLASPARTYLPHENYLALANYL (N METHYLPHENYL)GLYCYLLEUCYLMETHIONINE; LANEPITANT; N (ALPHA ETHYLBENZYL) 3 (CARBOXYMETHOXY) 2 PHENYLQUINOLINE 4 CARBOXAMIDE; N (ALPHA ETHYLBENZYL) 3 METHYL 2 PHENYL 4 QUINOLINECARBOXAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR AGONIST; NEUROKININ 3 RECEPTOR ANTAGONIST; RADIOLIGAND; SB 235375; SENKTIDE; SUBSTANCE P [3-11][3 (4 HYDROXYPHENYL)PROPYL][3 ARGININE 9 SARCOSINE 11 OXOMETHIONINE] I 125; SUBSTANCE P [9 SARCOSINE 11 OXOMETHIONINE]; SUBSTANCE P DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTORADIOGRAPHY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE RESPONSE; DRUG EFFECT; HEART RATE; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; SPINAL CORD; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC TONE; TACHYCARDIA; THORACIC SPINAL CORD;

ACETIC ACIDS; ANIMALS; AUTONOMIC NERVOUS SYSTEM; AUTORADIOGRAPHY; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPERTENSION; INDOLES; INJECTIONS, SPINAL; MALE; PEPTIDE FRAGMENTS; PIPERIDINES; QUINOLINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RATS, WISTAR; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-3; SPINAL CORD; SUBSTANCE P; THORACIC VERTEBRAE; UP-REGULATION;

EID: 33646426906     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706694     Document Type: Article

References (71)

1. 2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. Biophys. Res. Comm., 184, 1418-1424.
2. 3H-(3-MeHis2) thyrotropin-releasing hormone to spinal cord membranes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. Pharmacology, 37, 349-355.
3. 5-enkephalin to brain regions and spinal cord membranes of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Pharmacology, 46, 75-81.
4. BROUILLETTE, J. & COUTURE, R. (2002). Evidence for a GABA(B) receptor component in the spinal action of substance P (SP) on arterial blood pressure in the awake rat. Br. J. Pharmacol., 136, 1169-1177.
5. BUÑAG, R.D. & TAKAHASHI, H. (1981). Exaggerated sympathetic responses to bradykinin in spontaneously hypertensive rats. Hypertension, 3, 433-440.
6. BURMAN, K.J., MCKITRICK, D.J., MINSON, J.B., WEST, A., ARNOLDA, L.F. & LLEWELLYN-SMITH, I.J. (2001). Neurokinin-1 receptor immunoreactivity in hypotension sensitive sympathetic preganglionic neurons. Brain Res., 915, 238-243.
7. 1 receptor antagonists in the rat. Br. J. Pharmacol., 127, 717-728.
8. 3 receptor antagonists in the conscious rat. Br. J. Pharmacol., 122, 643-654.
9. CHEN, J., GAO, J., XUE, H., LIU, Y. & XU, C. (1990). The role of substance P of the central nervous system in the pathogenesis of spontaneously hypertensive rats. Proc. Chin. Acad. Med. Sci. Peking Union Med. Coll., 5, 153-156.
10. 2 receptors in the spinal cord of spontaneously hypertensive rats. Br. J. Pharmacol., 135, 1641-1654.
11. CLOUTIER, F., ONGALI, B., CAMPOS, M.M., THIBAULT, G., NEUGEBAUER, W. & COUTURE, R. (2004). Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Br. J. Pharmacol., 142, 285-296.
12. COUTURE, R., GUPTA, A., KÉROUAC, R., ESCHER, E. & REGOLI, D. (1987a). Spinal actions of substance P analogues on cardiovascular responses in the rat: a structure-activity analysis. Can. J. Physiol. Pharmacol., 65, 412-418.
13. COUTURE, R., GUPTA, A., KÉROUAC, R. & REGOLI, D. (1987b). Studies on the cardiovascular effects produced by the spinal action of two substance P analogues in the rat: evidence for a central catecholaminergic mechanism. Eur. J. Pharmacol., 135, 345-354.
14. COUTURE, R., LANEUVILLE, O., GUIMOND, C., DRAPEAU, G. & REGOLI, D. (1989). Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 547-557.
15. COUTURE, R., PICARD, P., POULAT, P. & PRAT, A. (1995). Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation. Can. J. Physiol. Pharmacol., 73, 892-902.
16. 125I-substance P in the rat. Peptides, 8, 213-221.
17. CULMAN, J., KLEE, S., OHLENDORF, C. & UNGER, T. (1997). Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J. Pharmacol. Exp. Ther., 280, 238-246.
18. 1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B. Br. J. Pharmacol., 114, 1310-1316.
19. CZYZEWSKA-SZAFRAN, H., WUTKIEWICZ, M., REMISZEWSKA, M., JASTRZEBSKI, Z., CZARNECKI, A. & DANYSZ, A. (1989). Down-regulation of the GABA-ergic system in selected brain areas of spontaneously hypertensive rats. Pol. J. Pharmacol. Pharm., 41, 619-627.
20. DE CHAMPLAIN, J. (2001). Do most antihypertensive agents have a sympatholytic action? Curr Hypertens. Rep, 3, 305-313.
21. DESCHAMPS, K. & COUTURE, R. (2005). The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. Br. J. Pharmacol., 145, 712-727.
22. DEUCHARS, S.A., MILLIGAN, C.J., STORNETTA, R.L. & DEUCHARS, J. (2005). GABAergic neurons in the central region of the spinal cord: a novel substrate for sympathetic inhibition. J. Neurosci, 25, 1063-1070.
23. GAIDA, W., LANG, R.E., KRAFT, K., UNGER, T. & GANTEN, D. (1985). Altered neuropeptide concentrations in spontaneously hypertensive rats: cause or consequence? Clin. Sci. (London), 68, 35-43.
24. GITTER, B.D., BRUNS, R.F., WATERS, D.C., THRELKELD, P., NIXON, J.L., LOBB, K.A., MASON, N.R., FOREMAN, M., MCNULTY, A., STENGEL, P., SILBAUGH, S.D., SCHOBER, D., GEHLERT, D.R., PHEBUS, L., IYENGAR, S., CALLIGARO, D., REGOLI, D. & HIPSKIND, P. (1995). Pharmacological characterization of LY303870: a novel, potent and selective non-peptide substance P (NK-1) receptor antagonist. J. Pharmacol. Exp. Biol., 275, 737-744.
25. GULATI, A. & REBELLO, S. (1992). Characteristics of endothelin receptors in the central nervous system of spontaneously hypertensive rats. Neuropharmacology, 31, 243-250.
26. HASSÉSSIAN, H. & COUTURE, R. (1989). Cardiovascular responses induced by intrathecal substance P in the conscious freely moving rat. J. Cardiovasc. Pharmacol., 13, 594-602.
27. HASSÉSSIAN, H., COUTURE, R. & DE CHAMPLAIN, J. (1990). Sympathoadrenal mechanisms underlying cardiovascular responses to intrathecal substance P in conscious rats. J. Cardiovasc. Pharmacol., 15, 736-744.
28. HASSÉSSIAN, H., DRAPEAU, G. & COUTURE, R. (1988). Spinal action of neurokinins producing cardiovascular responses in the conscious freely moving rat: evidence for a NK-1 receptor mechanism. Naunyn-Schmiedebergs Arch. Pharmacol., 338, 649-654.
29. HAY, D.W.P., GIARDINA, G.A.M., GRISWOLD, D.E., UNDERWOOD, D.C., KOTZER, C.J., BUSH, B., POTTS, W., SANDHU, P., LUNDBERG, D., FOLEY, J.J., SCHMIDT, D.B., MARTIN, L.D., KILIAN, D., LEGOS, J., BARONE, F.C., LUTTMANN, M.A., GRUGNI, M., RAVEGLIA, L.F. & SARAU, H.M. (2002). Nonpeptide tachykinin receptor antagonists: III. SB235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyperreactivity in guinea pigs. J. Pharmacol. Exp. Ther., 300, 314-323.
30. HOCK, F.J., WIRTH, K., ALBUS, U., LINZ, W., GERHARDS, H.J., WIEMER, G., HENKE, ST., BREIPOHL, G., KÖNIG, W., KNOLLE, J. & SCHÖLKENS, B.A. (1991). Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol., 102, 769-773.
31. HUNTER, W.M. & GREENWOOD, F.C. (1962). Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature, 194, 495-496.
32. B receptor in the brain of spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol., 22, S51-S53.
33. IYENGAR, S., HIPSKIND, P.A., GEHLERT, D.R., SCHOBER, D., LOBB, K.L., NIXON, J.A., HELTON, D.R., KALLMAN, M.J., BOUCHER, S., COUTURE, R., LI, D.L. & SIMMONS, R.M.A. (1997). LY303870, a centrally active neurokinin-1 antagonist with a long duration of action. J. Pharmacol. Exp. Therap., 280, 774-785.
34. KHAN, I.M., PRINTZ, M.P., YAKSH, T.L. & TAYLOR, P. (1994). Augmented responses to intrathecal nicotinic agonists in spontaneous hypertension. Hypertension, 24, 611-619.
35. KHAN, I.M., YOUNGBLOOD, K.L., PRINTZ, M.P., YAKSH, T.L. & TAYLOR, P. (1996). Spinal nicotinic receptor expression in spontaneously hypertensive rats. Hypertension, 28, 1093-1099.
36. LAFLAMME, A.K., OSTER, L., CARDINAL, R. & DE CHAMPLAIN, J. (1997). Effects of renin-angiotensin blockade on sympathetic reactivity and beta-adrenergic pathway in the spontaneously hypertensive rat. Hypertension, 30 (Part 1), 278-287.
37. 3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study. Br. J. Pharmacol., 138, 554-563.
38. LESSARD, A. & COUTURE, R. (2001). Modulation of cardiac activity by tachykinins in the rat substantia nigra. Br. J. Pharmacol., 134, 1749-1759.
39. 3 receptor antagonists in rat. Eur. J. Pharmacol., 486, 75-83.
40. LINDSEY, C.J. (1995). Central bradykinin receptors in the SHR and blood pressure. Prog. Hypertens., 3, 109-125.
41. LOPES, P. & COUTURE, R. (1992). Cardiovascular responses elicited by intrathecal kinins in the conscious rat. Eur. J. Pharmacol., 210, 137-147.
42. LOUIS, W.J., CONWAY, E.L., HOWES, L.G., MACCARRONE, C., BEART, P.M. & JARROTT, B. (1987). Neurotransmitters and neuropeptides in blood pressure regulation in the spontaneously hypertensive rat. Can. J. Physiol. Pharmacol., 65, 1633-1637.
43. MACCARRONE, C. & JARROTT, B. (1986). Age-related changes in neuropeptide Y immunoreactivity (NPY-ir) in the cortex and spinal cord of spontaneously hypertensive (SHR) and normotensive Wistar-Kyoto (WKY) rats. J. Hypertens., 4, 471-475.
44. MASSI, M., POLIDORI, C., PERFUMI, M., GENTILI, L. & DE CARO, G. (1991). Tachykinin receptor subtypes involved in the central effects of tachykinins on water and salt intake. Brain Res. Bull., 26, 155-160.
45. MIURA, M., TAKAYAMA, K. & OKADA, J. (1994). Distribution of glutamate- and GABA-immunoreactive neurons projecting to the cardioacceleratory center of the intermediolateral nucleus of the thoracic cord of SHR and WKY rats: a double-labeling study. Brain Res., 638, 139-150.
46. NAKAYAMA, Y., TAKANO, Y., SAITO, R. & KAMIYA, H. (1992). Central pressor actions of tachykinin NK-3 receptor in the paraventricular nucleus of the rat hypothalamus. Brain Res., 595, 339-342.
47. PAXINOS, G. & WATSON, C. (1998). The Rat Brain in Stereotaxic Coordinates. 4th edn. CA, U.S.A.: Academic Press, San Diego.
48. PHAM, T.M., DE CHAMPLAIN, J. & COUTURE, R. (1993). Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat. Naunyn-Schmiedebergs Arch. Pharmacol., 347, 42-49.
49. POLIDORI, C., SAIJA, A., PERFUMI, M., COSTA, G., DE CARO, G. & MASSI, M. (1989). Vasopressin release induced by intracranial injection of tachykinins is due to activation of central neurokinin-3 receptors. Neurosci. Lett., 103, 320-325.
50. POMPEI, P., TAYEBATI, S.J., POLIDORI, C., PERFUMI, M., DE CARO, G. & MASSI, M. (1993). Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. Peptides, 14, 97-102.
51. QADRI, F., BAURLE, L., HAUSER, W., RASCHER, W. & DOMINIAK, P. (1999). Centrally bradykinin B2-receptor-induced hypertensive and positive chronotropic effects are mediated via activation of the sympathetic nervous system. J. Hypertens., 17, 1265-1271.
52. REGOLI, D., DRAPEAU, G., DION, S. & COUTURE, R. (1988). New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol. Sci., 9, 290-295.
53. REJA, V., GOODCHILD, A.K. & PILOWSKY, P.M. (2002). Catecholamine-related gene expression correlates with blood pressure in SHR. Hypertension, 40, 342-347.
54. RIBEIRO-DA-SILVA, A., MCLEOD, A.L. & KRAUSE, J.E. (2000). Neurokinin receptors in the CNS. In: Handbook of Chemical Neuroanatomy. Quirion R., Björklund A. & Hökfelt T.H., eds. Peptide Receptors, Part I, Vol. 16, pp. 195-240. Amsterdam, The Netherlands: Elsevier Science B.V.
55. SARAU, H.M., GRISWOLD, D.E., BUSH, B., POTTS, W., SANDHU, P., LUNDBERG, D., FOLEY, J.J., SCHMIDT, D.B., WEBB, E.F., MARTIN, L.D., LEGOS, J.J., WHITMORE, R.G., BARONE, F.C., MEDHURST, A.D., LUTTMAN, MA., GIARDINA, G.A.M. & HAY, D.W.P. (2000). Nonpeptide tachykinin receptor antagonists: II. Pharmacological and pharmacokinetic profile of SB222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J. Pharmacol. Exp. The., 295, 373-381.
56. SASAKI, S., KUWABARA, T., YOSHITOMI, T., YONEDA, Y., TAKENAKA, K., TAKESAKO, T., TANAKA, M., HIRATA, M., TANABE, S., NAKATA, T., TAKEDA, K. & NAKAGAWA, M. (1992). Decreased hypothalamic and medullary GABA turnover in spontaneously hypertensive rats. Cardiovasc. Res., 26, 261-264.
57. SCHRAMM, L.P. & CHORNOBOY, E.S. (1982). Sympathetic activity in spontaneously hypertensive rats after spinal transection. Am. J. Physiol., 243, R506-R511.
58. SHIGEMATSU, K., NIWA, M., KURIHARA, M., CASTREN, E. & SAAVEDRA, J.M. (1987). Alterations in substance P binding in brain nuclei of spontaneously hypertensive rats. Am J. Physiol., 252 (2 Part 2), H301-H306.
59. SHULKES, A., LEWIS, S.J. & JARROTT, B. (1987). Strain differences in central nervous system neurotensin content between normotensive and spontaneously hypertensive rats. Brain Res., 415, 404-408.
60. SIEGL, P.K. (1993). Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist. J. Hypertens. Suppl., 11, S19-S22.
61. SOLOMON, S.G., LLEWELLYN-SMITH, I.J., MINSON, J.B., ARNOLDA, L.F., CHALMERS, J.P. & PILOWSKY, P.M. (1999). Neurokinin-1 receptors and spinal cord control of blood pressure in spontaneously hypertensive rats. Brain Res., 815, 116-120.
62. SUTER, C. & COOTE, J.H. (1987). Intrathecally administered angiotensin II increases sympathetic activity in the rat. J. Auton. Nerv. Syst., 19, 31-37.
63. SUZUKI, S., PILOWSKY, P., MINSON, J., ARNOLDA, L., LLEWELLYN-SMITH, I. & CHALMERS, J. (1995). Antisense to thyrotropin releasing hormone receptor reduces arterial blood pressure in spontaneously hypertensive rats. Circ. Res., 77, 679-683.
64. TAKANO, Y., NAGASHIMA, A., HAGIO, T., TATEISHI, K. & KAMIYA, H. (1990). Role of central tachykinin peptides in cardiovascular regulation in rats. Brain Res., 528, 231-237.
65. TAKANO, Y., SAWYER, W.B. & LOEWY, A.D. (1985). Substance P mechanisms of the spinal cord related to vasomotor tone in the spontaneously hypertensive rat. Brain Res., 334, 105-116.
66. TAN, C.K., TANG, F.R. & LING, E.A. (1996). Ultrastructural localization of substance P-like immunoreactivity in the intermediolateral column of spontaneously hypertensive rats and Wistar-Kyoto rats. Histol. Histopathol., 11, 303-311.
67. UNGER, T., CAROLUS, S., DEMMERT, G., GANTEN, D., LANG, R.E., MASER-GLUTH, C., STEINBERG, H. & VEELKEN, R. (1988). Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ. Res., 63, 812-820.
68. UNGER, T., RASCHER, W., SCHUSTER, C., PAVLOVITCH, R., SCHOMIG, A., DIETZ, R. & GANTEN, D. (1981). Central blood pressure effects of substance P and angiotensin II: role of the sympathetic nervous system and vasopressin. Eur. J. Pharmacol., 71, 33-42.
69. UNGER, T., ROCKHOLD, R.W., YUKIMURA, T., RETTIG, R. & GANTEN, D. (1980). Blood pressure and heart rate responses to centrally administered substance P are increased in spontaneously hypertensive rats. Clin. Sci. (London), 59, 299s-302s.
70. YAKSH, T.L. & RUDY, T.A. (1976). Chronic catheterization of the spinal subarachnoid space. Physiol. Behav., 17, 1031-1036.
71. YUAN, Y.D. & COUTURE, R. (1997). Renal effects of intracerebroventricularly injected tachykinins in the conscious saline-loaded rat: receptor characterization. Br. J. Pharmacol., 120, 785-796.